Close Menu

NEW YORK (GenomeWeb) – Color Genomics said this week in an SEC filing that it has raised $52 million thus far in a planned $80M funding round.

A company spokesperson added today that the financing is being led by General Catalyst, and also includes Emerson Collective and CRV.

According to Color CEO Othman Laraki, money raised in the round will be used to further invest in developing testing strategies for hereditary conditions, and to further other aspects of preventive medicine — focusing on areas where "the science is clear and the results are actionable."

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Politico notes that the Biden Administration has not yet nominated a permanent Food and Drug Administration commissioner. 

Anthony Fauci also informed the World Health Organization executive board that the US would be joining the COVAX initiative, according to CNBC.

A new preprint suggests some SARS-CoV-2 variants could affect the effectiveness of current vaccines, the Associated Press reports.

In Nature this week: Australian lungfish provides details on the movement of vertebrate life from water to land, and more.